You did briefly mention compulsory licensing. As I understand it, that's the power of the state. When a patent holder refuses to act on a patent and they have access to a life-saving molecule or something of great public interest, it allows the state to act on that patent if the private patent holder won't.
Is that something we could look at? If Vertex will not apply in Canada to make Trikafta available to the patients who need it, is compulsory licensing an option?